Evidence map›Paper›PMID 37654676›Full record

ArticleFrontiers in physiology2023

FG-4592 relieves diabetic kidney disease severity by influencing metabolic profiles via gut microbiota reconstruction in both human and mouse models.

Yumin Jiang, Wen Cui, Yiding Zhang, Ting Wang, Xuejun Zheng, Huangmin Li, Jin Shang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yumin JiangDepartment of Emergency Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wen CuiDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yiding ZhangDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ting WangDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xuejun ZhengDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Huangmin LiDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jin ShangDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetic kidney diseaseFG-4592gut microbiotamechanismuntargeted metabolomics analysis

Identifiers

PMID37654676
PMCPMC10465800
OpenAlexW4385953462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.